Insiders · PTIX

PTIX insider transactions

Protagenic Therapeutics Inc. (PTIX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PTIX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Protagenic Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Garo H ArmenExec. Chair & Principal Off, Director+$30.7K
• Barrett Evansex CEO, Director, 10% owner, since May 2025
• Timothy R WrightDirector
• Khalil BarrageDirector
• Robert Benjamin SteinDirector
• Jennifer BuellDirector
• Brian CorveseDirector
• Alexander K. ArrowChief Financial Officer+$28.6K

Recent Form 3, 4, and 5 filings for PTIX

• 80d
  EXEC. CHAIR & PRINCIPAL OFF Armen Garo H bought $13,000 worth of shares (20,000 units at $0.65), increasing direct ownership by 37% to 73,533 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 83d
  EXEC. CHAIR & PRINCIPAL OFF Armen Garo H bought $9,811 worth of shares (16,634 units at $0.59), increasing direct ownership by 45% to 53,533 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 84d
  EXEC. CHAIR & PRINCIPAL OFF Armen Garo H bought $945 worth of shares (2,700 units at $0.35), increasing direct ownership by 8% to 36,899 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 92d
  EXEC. CHAIR & PRINCIPAL OFF Armen Garo H bought $710 worth of shares (2,220 units at $0.32), increasing direct ownership by 7% to 34,199 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 94d
  EXEC. CHAIR & PRINCIPAL OFF Armen Garo H bought $151 worth of shares (685 units at $0.22), increasing direct ownership by 2% to 31,979 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 97d
  EXEC. CHAIR & PRINCIPAL OFF Armen Garo H bought $1,294 worth of shares (5,000 units at $0.26), increasing direct ownership by 19% to 31,294 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 101d
  EXEC. CHAIR & PRINCIPAL OFF. Armen Garo H bought $4,806 worth of shares (26,291 units at $0.18) (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 384d
  New insider Evans Barrett claimed ownership of 787 units of Preferred Stock Series C, claimed ownership of 131,034 units of Preferred Stock Series C-1, claimed ownership of 6,498 units of Preferred Stock Series D and claimed ownership of 16,233 shares (SEC Form 3)

  3 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 954d
  SEC Form 4 filed by Wright Timothy R

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 957d
  SEC Form 4 filed by Barrage Khalil

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 957d
  SEC Form 4 filed by Stein Robert Benjamin

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 957d
  SEC Form 4 filed by Buell Jennifer

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 957d
  SEC Form 4 filed by Corvese Brian

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 957d
  SEC Form 4 filed by Armen Garo H

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 957d
  SEC Form 4 filed by Arrow Alexander K.

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 1126d
  Arrow Alexander K. bought $6,480 worth of PTIX Common Stock (8,000 units at $0.81), increasing direct ownership by 21% to 45,815 units (SEC Form 4)

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 1639d
  SEC Form 4: Arrow Alexander K. bought $22,090 worth of PTIX Common Stock (31,000 units at $0.71), increasing direct ownership by 26% to 151,260 units

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 1988d
  SEC Form 4 filed by Arrow Alexander K.

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 1990d
  SEC Form 4 filed by Barrage Khalil

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 1990d
  SEC Form 4 filed by Arrow Alexander K.

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)
• 2002d
  SEC Form 4 filed by Arrow Alexander K.

  4 - Protagenic Therapeutics, Inc.\new (0001022899) (Issuer)